Study to measure the impact of whole genome sequencing in pa

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.

Related Keywords

United States , Herb Aronow , Phil Febbo , Emily Henderson , David Lanfear , American College Of Medical Geneticists , World Health Organization , Translational Research At Henry Ford Health , Henry Ford Health , Drug Administration , Heart Vascular Services At Henry Ford Health , Clinical Pharmacogenetics Implementation Consortium , Christopher Jeffries Center , Genomic Medicine Research At Henry Ford Health , Illumina Inc , Ford Health , Cardiovascular Medicine , Henry Ford , Precision Medicine , Genomic Medicine Research , Vice President , Translational Research , Medical Director , Vascular Services , Chief Medical Officer , American College , Medical Geneticists , Genomic , Heart , Heart Disease , Dancer , Cardiovascular Disease , Na , Na Sequencing , Genes , Enetic , Enome , Genomics , Health Care , Healthcare , Illumina , Medicine , Rthopedics , Research , Sports Medicine , Whole Genome Sequencing ,